Concepedia

Author

D. Vassilief

Hôpital Cochin

Also Known As

D Vassilief, D. Vassilief, Dominique Vassilief

14

Publications

428

Citations

7

H-Index

16

Concepts

All Affiliations

Hôpital CochinUniversité Sorbonne Paris NordHôpital AvicenneGroupe Francophone des MyélodysplasiesHôpital Purpan
DV

About

D. Vassilief is an author at Hôpital Cochin specializing in hematology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

292

2

Health Sciences

1

1

48

3

Cell Biology

1

1

30

4

Emergency Medicine

1

1

48

5

Pathology

1

1

30

D. Vassilief

×

7

Publications

403

Citations

7

H-Index

YearCitations

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM

Christian Rosé, Sabine Bréchignac, D. Vassilief,

Leukemia Research

2010

195

Positive Impact of Iron Chelation Therapy (CT) on Survival in Regularly Transfused MDS Patients. A Prospective Analysis by the GFM.

Christian Rosé, Sabine Bréchignac, D. Vassilief,

Blood

2007

73

A non‐randomised dose‐escalating phase II study of thalidomide for the treatment of patients with low‐risk myelodysplastic syndromes: the Thal‐SMD‐2000 trial of the Groupe Français des Myélodysplasies

Didier Bouscary, Laurence Legros, M Tulliez,

British Journal of Haematology

2005

48

Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases

Raphaël Itzykson, Sameh Ayari, D. Vassilief,

Leukemia

2009

30

Unusual occurrence of spontaneous haematomas in three asymptomatic HIV-infected haemophilia patients a few days after the onset of ritonavir treatment.

Charles M. Ginsburg, Dominique Salmon‐Céron, D. Vassilief,

PubMed

1997

24

Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes

Jérôme Tamburini, C. Elie, Sophie Park,

Leukemia Research

2008

19

High Response Rate to Darbopoetin Alfa in “Low Risk” MDS : Results of a Phase II Study.

Lionel Mannone, Claude Gardin, M.C. Quarré,

Blood

2004

14

Page 1